ibopamine has been researched along with Left Ventricular Dysfunction in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pouleur, H | 1 |
| Boomsma, F; Charlesworth, A; de Kam, PJ; de Zeeuw, D; Girbes, AR; Hampton, JR; Hillege, HL; van Veldhuisen, DJ | 1 |
1 review(s) available for ibopamine and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Neurohormonal and hemodynamic effects of ibopamine.
Topics: Clinical Trials as Topic; Deoxyepinephrine; Dopamine Agonists; Heart Failure; Hemodynamics; Humans; Kidney; Levodopa; Norepinephrine; Ventricular Dysfunction, Left | 1995 |
1 trial(s) available for ibopamine and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Renal function, neurohormonal activation, and survival in patients with chronic heart failure.
Topics: Aged; Aldosterone; Atrial Natriuretic Factor; Cardiac Output; Cardiotonic Agents; Catecholamines; Chronic Disease; Deoxyepinephrine; Dopamine; Epinephrine; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Male; Middle Aged; New York; Norepinephrine; Predictive Value of Tests; Prognosis; Prospective Studies; Protein Precursors; Renin; Renin-Angiotensin System; Survival Analysis; Ventricular Dysfunction, Left; Ventricular Function, Left | 2000 |